Heramed Share Price and Company Fundamentals



Price
$0.044
Change
-0.001 (-2.222%)
52 week range
0.0065 - 0.049

Last traded: Today at 4:33 AM

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant mothers. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.

Key Metrics

PE ratio

-

PB ratio

44.00

Dividend yield

-

Beta

0.73

Market cap

$47.09M

Enterprise value

$37.57M

Company profile

Industry / Sector Medical Devices / Healthcare
Website https://www.hera-med.com
Mailing address 117 Camberwell Road Suite 1.01 Hawthorn East VIC 3123 Australia
Phone / Fax 61 2 7251 1888 / 61 2 7251 1888

Dividends

More: Heramed Dividend history, yield and payout ratio

Dividend yield

-

Dividend amount

$-

Payout ratio

0.00%

5Y Avg. yield

-%

Heramed paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.HMD dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

Company Executives

As of Feb 2026, following are the company executives and directors listed on Heramed.

Name Title Age Total Pay
Ms. Anoushka Gungadin MD, CEO & Director
Mr. Cameron Peter Jones C.A. CFO & Company Secretary
Henry Jordan Head of Investor Relations
Dr. Arturo Weschler M.D. C.M.O
Dr. Mandy Khaira Chief Clinical Transformation Officer & Chief Medical Officer
Ms. Stephanie Vipond Joint Company Secretary

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-1183.55%

Return on assets

-105.38%

Return on equity

-518.37%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Heramed is 47.09M and its enterprise value is 37.57M. The enterprise value to revenue ratio of HMD is 116.35. The enterprise value to EBITDA ratio of HMD is -9.25.

The HMD's stocks Beta value is 0.73 making it 27% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Heramed (HMD)

Heramed (ASX:HMD) Frequently Asked Questions

1. What is Heramed's Stock Symbol?

Heramed trades on ASX under the ticker symbol "HMD".

2. What is Heramed's stock price today?

One share of HMD stock can currently be purchased for approximately $0.044.

3. How can I contact Heramed?

Heramed's mailing address is 117 Camberwell Road Suite 1.01 Hawthorn East VIC 3123 Australia. The company can be reached via phone at 61 2 7251 1888.

4. What is Heramed's official website?

The official website of Heramed is https://www.hera-med.com.